Journal of Modern OncologyJournal of Modern OncologyСовременная онкология1815-14341815-1442LLC Obyedinennaya Redaktsiya29493ArticlesСтатьиOpyt primeneniya bendamustina u patsientov s retsidivom khronicheskogo limfoleykoza v rezhime monoterapii v ambulatornykh usloviyakhОпыт применения бендамустина у пациентов с рецидивом хронического лимфолейкоза в режиме монотерапии в амбулаторных условияхIvashchenkoA VИващенкоА В

НУЗ ДКБ ОАО Российские железные дороги, Ростов-на-Дону

НУЗ ДКБ ОАО Российские железные дороги, Ростов-на-Дону15092012143NO3 (2012)ТОМ 14, №3 (2012)131509042020Copyright ©; 2012, Consilium MedicumCopyright ©; 2012, ООО "Консилиум Медикум"2012Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc/4.0https://modernonco.orscience.ru/1815-1434/article/view/29493

1. Jemal A, Clegg LX, Ward E et al. Annual report to the nacional on the status of cancer 1975-2004, wild a special feature regarding survival. Cancer 2004; 101: 3-27.2. Волкова М.А. Клиническая онкогематология. М.: Медицина, 2007.3. Gridden JG. How I treat CLL up front. Blood 2010; 115: 187-97.4. Hallek M, Cheson BD, Catovski D et al. Guidelines and treatment of chronic lymphocytic leukemia: a report from the internacional Workshop Chronic Lymphocytik leukemia updating the Nacional Cancer Institute - Working Grоup 1996 quidelines. Blood 2008; 111: 5446-56.5. Donher H, Stilgenbauer S, Benner A et al. Genоmic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910-6.6. Chemoterapeutic option in chronic lymphocytic leukemia: A meta-analysis of the randomized trials: CLL Trialis Collaborative Group. J Natl Cancer Inst 1999; 90: 861-8.7. Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1750-7.8. Hallek M, Fisher K, Fingerle-Rovson G et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukemia: A randomized, open-label, phase 3 trial. Lancet 2010; 376: 1164-74.9. Fischer K et al Bendamustine in combination with rituximab for patients with reapsed chronic lymphocytic leukemia: a multicentre phase II trail of German CLL Study Group. ASH Annual Meeting Abstracts 2008; 112 (11): 330.10. Rummel M, Kaizer U, Balzer C et al. Bendamustine Plus Rituximab Versus Fludarabine Rituximab in patiens with Relapsed Follicular, indolent and Mantle Cell Lymphomas - final Results of Randomized phase III Study NHL 2003; 2.